| Bioactivity | Relfovetmab is an anti-NGF monoclonal antibody (mAb)[1]. |
| Name | Relfovetmab |
| CAS | 2171034-70-9 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Liu Wenshe Ray, et al. Protease switch for dual targets chimeric antigen receptor T-cell therapy. Patent. WO2021087245. |